Saturday 17 October 2026
Export ECOR’s income statement to Excel — free account
electroCore, Inc.
ECOR Healthcare Medical Devices
electroCore, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $32.0 million, up 27.2% from fiscal 2024. In the quarter to June 2026, revenue grew 28.0%, EPS grew 25.0% and free cash flow fell 443.5%, each against the same quarter a year earlier. Revenue growth for five consecutive years; insiders bought in the last twelve months.
7.85
0.50
−5.99%
Follow ECOR
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
Piotroski F-Score |
+8 more TTM periods Free account |
3 | 3 | 3 | 4 |
| (337.84%) | (478.70%) | 2,325.32% | 1,761.48% | ||
| (66.70%) | (71.37%) | (97.59%) | (93.41%) | ||
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | |
Return on Tangible Assets |
(262.20%) | (297.15%) | (2,665.86%) | (523.02%) | |
Average Days of Receivables |
18.08 | 11.70 | 9.12 | 8.98 | |
Free Cash Flow per Share |
(0.95) | (0.97) | (0.77) | (1.04) | |
Free Cash Flow |
(8.01) | (8.25) | (6.87) | (9.74) | |
Capital Expenditures |
(0.11) | (0.07) | (0.03) | (0.01) | |
| Other line items | |||||
Cash ROIC |
(42.93%) | (49.99%) | (69.91%) | (74.83%) | |
Accounts Receivable Turnover |
29.39 | 26.76 | 29.94 | 42.93 | |
Accounts Payable Turnover |
1.93 | 1.87 | 2.26 | 2.02 | |
Inventory Turnover |
2.63 | 2.57 | 2.40 | 2.49 | |
Average Days of Payables |
268.95 | 233.24 | 178.28 | 166.37 | |
Days of Inventory on Hand |
106.04 | 140.27 | 162.20 | 184.45 | |
Tax Rate |
0.00 | 0.00 | (0.02) | 0.00 | |
Research and Development Expense of Revenue |
8.78% | 8.54% | 8.12% | 8.49% | |
Selling, General and Administrative Expense of Revenue |
121.78% | 119.27% | 121.10% | 116.20% | |
Share Based Compensation of Revenue |
6.62% | 6.03% | 6.95% | 7.24% | |
Interest Coverage |
(22.06) | (22.29) | (16.22) | (11.41) | |
Operating CF/Net income |
0.56 | 0.59 | 0.44 | 0.66 | |
Depreciation/Fixed assets |
5.01 | 1.66 | 1.03 | 1.46 | |
Capex/Depreciation |
(0.11) | (0.10) | (0.08) | (0.02) | |
Revenue per Share |
3.53 | 3.78 | 3.90 | 3.93 | |
Operating CF per Share |
(0.94) | (0.97) | (0.76) | (1.04) | |
Capex per Share |
(0.01) | (0.01) | 0.00 | 0.00 | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 |
Columns are period end dates